NO20010082D0 - Farnesyl proteintransferaseinhibitorer med in vivo radiosensibiliserende egenskaper - Google Patents
Farnesyl proteintransferaseinhibitorer med in vivo radiosensibiliserende egenskaperInfo
- Publication number
- NO20010082D0 NO20010082D0 NO20010082A NO20010082A NO20010082D0 NO 20010082 D0 NO20010082 D0 NO 20010082D0 NO 20010082 A NO20010082 A NO 20010082A NO 20010082 A NO20010082 A NO 20010082A NO 20010082 D0 NO20010082 D0 NO 20010082D0
- Authority
- NO
- Norway
- Prior art keywords
- protein transferase
- transferase inhibitors
- farnesyl protein
- radiosensitizing properties
- vivo
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98202257 | 1998-07-06 | ||
EP98204330 | 1998-12-18 | ||
PCT/EP1999/004545 WO2000001411A1 (en) | 1998-07-06 | 1999-06-30 | Farnesyl protein transferase inhibitors with in vivo radiosensitizing properties |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20010082D0 true NO20010082D0 (no) | 2001-01-05 |
NO20010082L NO20010082L (no) | 2001-01-05 |
NO328178B1 NO328178B1 (no) | 2009-12-28 |
Family
ID=26150503
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20010082A NO328178B1 (no) | 1998-07-06 | 2001-01-05 | Anvendelse av farnesyl proteintransferaseinhibitorer for fremstilling av en farmasoytisk sammensetning med in vivo radiosensibiliserende egenskaper |
Country Status (31)
Country | Link |
---|---|
US (1) | US6545020B1 (no) |
EP (1) | EP1094839B1 (no) |
JP (1) | JP4530537B2 (no) |
KR (1) | KR100591603B1 (no) |
CN (1) | CN1152716C (no) |
AP (1) | AP1599A (no) |
AT (1) | ATE238811T1 (no) |
AU (1) | AU762423B2 (no) |
BG (1) | BG64941B1 (no) |
BR (1) | BR9911861A (no) |
CA (1) | CA2336624C (no) |
CZ (1) | CZ300968B6 (no) |
DE (1) | DE69907461T2 (no) |
DK (1) | DK1094839T3 (no) |
EA (1) | EA003877B1 (no) |
EE (1) | EE04582B1 (no) |
ES (1) | ES2199579T3 (no) |
HK (1) | HK1034451A1 (no) |
HR (1) | HRP20000903A2 (no) |
HU (1) | HU229076B1 (no) |
ID (1) | ID26987A (no) |
IL (2) | IL140721A0 (no) |
MY (1) | MY126519A (no) |
NO (1) | NO328178B1 (no) |
PL (1) | PL193464B1 (no) |
PT (1) | PT1094839E (no) |
SI (1) | SI1094839T1 (no) |
SK (1) | SK284723B6 (no) |
TR (1) | TR200003879T2 (no) |
TW (1) | TW586937B (no) |
WO (1) | WO2000001411A1 (no) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1094839T3 (da) | 1998-07-06 | 2003-08-18 | Janssen Pharmaceutica Nv | Farnesylproteintransferaseinhibitorer med in vivo radiosensibiliserende egenskaber |
EE04579B1 (et) | 1998-07-06 | 2006-02-15 | Janssen Pharmaceutica N.V. | Farnesüülproteiintransferaasi inhibiitorite kasutamine farmatseutilise kompositsiooni valmistamiseks, mis on ette nähtud artropaatiate raviks |
ES2262626T3 (es) * | 2000-02-04 | 2006-12-01 | Janssen Pharmaceutica N.V. | Inhibidores de farnesil proteina transferasa para tratar cancer de mama. |
JO2361B1 (en) * | 2000-06-22 | 2006-12-12 | جانسين فارماسيوتيكا ان. في | Enaniumer 1,2-anylated quinoline inhibitor for the transporter - farnesyl |
US7053105B2 (en) | 2000-09-25 | 2006-05-30 | Janssen Pharmaceutica, N.V. | Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors |
JP4974438B2 (ja) | 2000-09-25 | 2012-07-11 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ファルネシルトランスフェラーゼを阻害する6−ヘテロシクリルメチルキノリンおよびキナゾリン誘導体 |
JP4974439B2 (ja) | 2000-09-25 | 2012-07-11 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ファルネシルトランスフェラーゼを阻害する6−ヘテロシクリルメチルキノリノン誘導体 |
WO2002024683A1 (en) | 2000-09-25 | 2002-03-28 | Janssen Pharmaceutica N.V. | Farnesyl transferase inhibiting 6-[(substituted phenyl)methyl]-quinoline and quinazoline derivatives |
DE60139080D1 (de) | 2000-11-21 | 2009-08-06 | Janssen Pharmaceutica Nv | Farnesyltransferase hemmende benzoheterocyclische derivate |
DE60117847T2 (de) | 2000-12-27 | 2006-11-16 | Janssen Pharmaceutica N.V. | Farnesyltransferase hemmende, in der 4-stellung substituierte chinolin- und chinazolinderivate |
PT1351954E (pt) * | 2000-12-27 | 2006-09-29 | Janssen Pharmaceutica Nv | Derivados 4-heterociclil-quinolina e quinazolina inibidores da farnesil-transferase |
EP1408971A4 (en) | 2001-06-21 | 2006-01-25 | Ariad Pharma Inc | NEW QUINOLINES AND THEIR USES |
AU2002358677B2 (en) | 2001-12-19 | 2008-02-07 | Janssen Pharmaceutica N.V. | 1,8-annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors |
CA2478813C (en) | 2002-03-22 | 2011-10-18 | Janssen Pharmaceutica N.V. | Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors |
ATE336496T1 (de) | 2002-04-15 | 2006-09-15 | Janssen Pharmaceutica Nv | Farnesyl transferase hemmende tricyclische quinazolinederivate substitutiert mit kohlenstoff-gebundenen imidazolen oder triazolen |
KR101118582B1 (ko) * | 2003-11-20 | 2012-02-27 | 얀센 파마슈티카 엔.브이. | 폴리(adp-리보스)폴리머라제 저해제로서의 6-알케닐 및6-페닐알킬 치환된 2-퀴놀리논 및 2-퀴녹살리논 |
JP4691041B2 (ja) | 2003-11-20 | 2011-06-01 | チルドレンズ ホスピタル メディカル センター | Gtpアーゼ阻害剤および使用方法 |
WO2005089515A2 (en) * | 2004-03-18 | 2005-09-29 | The Brigham And Women's Hospital, Inc. | Methods for the treatment of synucleinopathies |
US20050277629A1 (en) * | 2004-03-18 | 2005-12-15 | The Brigham And Women's Hospital, Inc. | Methods for the treatment of synucleinopathies (Lansbury) |
US20070293539A1 (en) * | 2004-03-18 | 2007-12-20 | Lansbury Peter T | Methods for the treatment of synucleinopathies |
CA2559282A1 (en) * | 2004-03-18 | 2005-09-29 | Brigham And Women's Hospital, Inc. | Methods for the treatment of synucleinopathies |
WO2005089504A2 (en) * | 2004-03-18 | 2005-09-29 | The Brigham And Women's Hospital, Inc. | Methods for the treatment of synucleinopathies |
WO2005089518A2 (en) * | 2004-03-18 | 2005-09-29 | The Brigham And Women's Hospital, Inc. | Uch-l1 expression and cancer therapy |
US20060194821A1 (en) * | 2005-02-18 | 2006-08-31 | The Brigham And Women's Hospital, Inc. | Compounds inhibiting the aggregation of superoxide dismutase-1 |
AU2006275528B2 (en) | 2005-07-29 | 2012-03-08 | Children's Hospital Medical Center | GTPase inhibitors and methods of use and crystal structure of Rac-1 GTPase |
CA2634598A1 (en) | 2005-12-23 | 2007-07-05 | Link Medicine Corporation | Treatment of synucleinopathies |
JP2010528034A (ja) * | 2007-05-23 | 2010-08-19 | アラーガン、インコーポレイテッド | 医薬としての((フェニル)イミダゾリル)メチルキノリニル化合物 |
WO2009151683A2 (en) * | 2008-03-12 | 2009-12-17 | Link Medicine Corporation | Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications |
EP2138844B1 (en) | 2008-06-26 | 2012-04-25 | SpheroTec GmbH | Method for testing the response of cells to exposures with therapeutics |
US20110060005A1 (en) * | 2008-11-13 | 2011-03-10 | Link Medicine Corporation | Treatment of mitochondrial disorders using a farnesyl transferase inhibitor |
JP2012508768A (ja) * | 2008-11-13 | 2012-04-12 | リンク・メディスン・コーポレーション | アザキノリノン誘導体及びその使用 |
US20100331363A1 (en) * | 2008-11-13 | 2010-12-30 | Link Medicine Corporation | Treatment of mitochondrial disorders using a farnesyl transferase inhibitor |
US9980942B2 (en) | 2012-05-02 | 2018-05-29 | Children's Hospital Medical Center | Rejuvenation of precursor cells |
WO2014062658A1 (en) | 2012-10-16 | 2014-04-24 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of ror-gamma-t |
EP2909193B1 (en) | 2012-10-16 | 2017-04-19 | Janssen Pharmaceutica NV | Phenyl linked quinolinyl modulators of ror-gamma-t |
BR112015008515A2 (pt) | 2012-10-16 | 2017-07-04 | Janssen Pharmaceutica Nv | moduladores de ror t de quinolinila ligada à heteroarila |
KR20160070133A (ko) | 2013-10-15 | 2016-06-17 | 얀센 파마슈티카 엔.브이. | RORyt의 알킬 결합 퀴놀리닐 조절제 |
US9403816B2 (en) | 2013-10-15 | 2016-08-02 | Janssen Pharmaceutica Nv | Phenyl linked quinolinyl modulators of RORγt |
US9221804B2 (en) | 2013-10-15 | 2015-12-29 | Janssen Pharmaceutica Nv | Secondary alcohol quinolinyl modulators of RORγt |
US9284308B2 (en) | 2013-10-15 | 2016-03-15 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of RORγt |
KR20160068956A (ko) | 2013-10-15 | 2016-06-15 | 얀센 파마슈티카 엔.브이. | RORyT의 퀴놀리닐 조절제 |
US9328095B2 (en) | 2013-10-15 | 2016-05-03 | Janssen Pharmaceutica Nv | Heteroaryl linked quinolinyl modulators of RORgammat |
US10555941B2 (en) | 2013-10-15 | 2020-02-11 | Janssen Pharmaceutica Nv | Alkyl linked quinolinyl modulators of RORγt |
US10028503B2 (en) | 2014-06-18 | 2018-07-24 | Children's Hospital Medical Center | Platelet storage methods and compositions for same |
HUE049620T2 (hu) | 2015-08-17 | 2020-09-28 | Kura Oncology Inc | Módszerek rákos páciensek kezelésére farneziltranszferáz inhibitorokkal |
WO2017184968A1 (en) | 2016-04-22 | 2017-10-26 | Kura Oncology, Inc. | Methods of selecting cancer patients for treatment with farnesyltransferase inhibitors |
ES2863730T3 (es) | 2016-11-03 | 2021-10-11 | Kura Oncology Inc | Inhibidores de la farnesiltransferasa para uso en el tratamiento del cáncer |
US9956215B1 (en) | 2017-02-21 | 2018-05-01 | Kura Oncology, Inc. | Methods of treating cancer with farnesyltransferase inhibitors |
CA3053795A1 (en) | 2017-02-21 | 2018-08-30 | Kura Oncology, Inc. | Methods of treating cancer with farnesyltransferase inhibitors |
EP3664804A4 (en) | 2017-08-07 | 2021-04-14 | Kura Oncology, Inc. | METHOD OF TREATMENT OF CANCER WITH FERN SYL TRANSFERASE INHIBITORS |
US10806730B2 (en) | 2017-08-07 | 2020-10-20 | Kura Oncology, Inc. | Methods of treating cancer with farnesyltransferase inhibitors |
WO2019113269A1 (en) | 2017-12-08 | 2019-06-13 | Kura Oncology, Inc. | Methods of treating cancer patients with farnesyltransferase inhibitors |
CA3117968A1 (en) | 2018-11-01 | 2020-05-07 | Kura Oncology, Inc. | Methods of treating cancer with farnesyltransferase inhibitors |
WO2020180663A1 (en) | 2019-03-01 | 2020-09-10 | Kura Oncology, Inc. | Methods of treating cancer with farnesyltransferase inhibitors |
WO2020190604A1 (en) | 2019-03-15 | 2020-09-24 | Kura Oncology, Inc. | Methods of treating cancer patients with farnesyltransferase inhibitors |
WO2020205486A1 (en) | 2019-03-29 | 2020-10-08 | Kura Oncology, Inc. | Methods of treating squamous cell carcinomas with farnesyltransferase inhibitors |
US20220168296A1 (en) | 2019-04-01 | 2022-06-02 | Kura Oncology, Inc. | Methods of treating cancer with farnesyltransferase inhibitors |
US20220305001A1 (en) | 2019-05-02 | 2022-09-29 | Kura Oncology, Inc. | Methods of treating acute myeloid leukemia with farnesyltransferase inhibitors |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5141851A (en) * | 1990-04-18 | 1992-08-25 | Board Of Regents, The University Of Texas System | Isolated farnesyl protein transferase enzyme |
US6083917A (en) * | 1990-04-18 | 2000-07-04 | Board Of Regents, The University Of Texas System | Methods and compositions for the identification, characterization and inhibition of farnesyltransferase |
US5602184A (en) * | 1993-03-03 | 1997-02-11 | The United States Of America As Represented By Department Of Health And Human Services | Monoterpenes, sesquiterpenes and diterpenes as cancer therapy |
TW349948B (en) * | 1995-10-31 | 1999-01-11 | Janssen Pharmaceutica Nv | Farnesyl transferase inhibiting 2-quinolone derivatives |
CA2231105C (en) * | 1995-12-08 | 2005-09-13 | Janssen Pharmaceutica N.V. | Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives |
JP2000508661A (ja) * | 1996-04-15 | 2000-07-11 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | 放射線および化学療法に対する細胞の感作 |
EP0918771A4 (en) * | 1996-07-15 | 2001-02-07 | Bristol Myers Squibb Co | THIADIOXOBENZODIAZEPINES FOR USE AS FARNESYL PROTEIN TRANSFERASE INHIBITORS |
TW591030B (en) | 1997-03-10 | 2004-06-11 | Janssen Pharmaceutica Nv | Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles |
DK1094839T3 (da) | 1998-07-06 | 2003-08-18 | Janssen Pharmaceutica Nv | Farnesylproteintransferaseinhibitorer med in vivo radiosensibiliserende egenskaber |
CN1340051A (zh) * | 1999-02-11 | 2002-03-13 | 辉瑞产品公司 | 可用作抗癌剂的杂芳基取代的喹啉-2-酮衍生物 |
-
1999
- 1999-06-30 DK DK99931229T patent/DK1094839T3/da active
- 1999-06-30 CA CA002336624A patent/CA2336624C/en not_active Expired - Lifetime
- 1999-06-30 ES ES99931229T patent/ES2199579T3/es not_active Expired - Lifetime
- 1999-06-30 EE EEP200000794A patent/EE04582B1/xx unknown
- 1999-06-30 KR KR1020007014066A patent/KR100591603B1/ko not_active IP Right Cessation
- 1999-06-30 IL IL14072199A patent/IL140721A0/xx active IP Right Grant
- 1999-06-30 SK SK1986-2000A patent/SK284723B6/sk not_active IP Right Cessation
- 1999-06-30 PL PL99347979A patent/PL193464B1/pl unknown
- 1999-06-30 JP JP2000557857A patent/JP4530537B2/ja not_active Expired - Lifetime
- 1999-06-30 BR BR9911861-0A patent/BR9911861A/pt not_active Application Discontinuation
- 1999-06-30 AU AU47805/99A patent/AU762423B2/en not_active Expired
- 1999-06-30 PT PT99931229T patent/PT1094839E/pt unknown
- 1999-06-30 US US09/743,130 patent/US6545020B1/en not_active Expired - Lifetime
- 1999-06-30 AT AT99931229T patent/ATE238811T1/de active
- 1999-06-30 AP APAP/P/2001/002057A patent/AP1599A/en active
- 1999-06-30 EP EP99931229A patent/EP1094839B1/en not_active Expired - Lifetime
- 1999-06-30 ID IDW20010020A patent/ID26987A/id unknown
- 1999-06-30 EA EA200100111A patent/EA003877B1/ru not_active IP Right Cessation
- 1999-06-30 CN CNB998082678A patent/CN1152716C/zh not_active Expired - Lifetime
- 1999-06-30 DE DE69907461T patent/DE69907461T2/de not_active Expired - Lifetime
- 1999-06-30 TR TR2000/03879T patent/TR200003879T2/xx unknown
- 1999-06-30 HU HU0103689A patent/HU229076B1/hu unknown
- 1999-06-30 CZ CZ20004777A patent/CZ300968B6/cs not_active IP Right Cessation
- 1999-06-30 WO PCT/EP1999/004545 patent/WO2000001411A1/en active IP Right Grant
- 1999-06-30 SI SI9930332T patent/SI1094839T1/xx unknown
- 1999-07-01 MY MYPI99002794A patent/MY126519A/en unknown
- 1999-07-05 TW TW088111346A patent/TW586937B/zh not_active IP Right Cessation
-
2000
- 2000-12-28 HR HR20000903A patent/HRP20000903A2/hr not_active Application Discontinuation
-
2001
- 2001-01-03 BG BG105108A patent/BG64941B1/bg unknown
- 2001-01-04 IL IL140721A patent/IL140721A/en not_active IP Right Cessation
- 2001-01-05 NO NO20010082A patent/NO328178B1/no not_active IP Right Cessation
- 2001-07-18 HK HK01105023A patent/HK1034451A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1094839T3 (da) | Farnesylproteintransferaseinhibitorer med in vivo radiosensibiliserende egenskaber | |
EE04309B1 (et) | Farnesüül-proteiini transferaasi inhibiitorid | |
EE9800408A (et) | Proteiinfarnesüültransferaasi inhibiitorid | |
IS6183A (is) | Díamínóþíazol og notagildi þeirra til að hindra prótín kínasa | |
NO996571D0 (no) | Inhibitorer for farnesyl-protein-transferase | |
CY2014034I1 (el) | Υποκατεστημενες 3-κυανοκινολινες ως αναστολεις κινασων πρωτεϊνης τυροσινης | |
ATE546139T1 (de) | Isoprentransferase proteine inhibitoren | |
EE200300085A (et) | Pürasooli derivaadid ja nende kasutamine proteiini kinaasi inhibiitoritena | |
FI951554A0 (fi) | Imidatsolipitoisia farnesyyliproteiinitransferaasi-inhibiittoreita | |
DE69924876D1 (de) | Farnesyl protein transferase inhibitoren | |
ATE255114T1 (de) | Tricyclische proteinkinasehemmer | |
ATE273299T1 (de) | Benzpyrido cycloheptan derivate mit farnesyl protein transferase inhibierender wirkung | |
NO20005680D0 (no) | Kombinasjoner av protein-farnesyltransferase og HMG CoA reduktase inhibitorer og anvendelse derav for behandling av cancer | |
HUP0202152A2 (en) | Tricyclyc farnesyl protein transferase inhibitors | |
EE200200206A (et) | Farnesüüli transferaasiinhibiitorid | |
AU3514302A (en) | 0ovel farnesyl protein transferase inhibitors | |
DK1087981T3 (da) | Prenyltransferaseinhibitorer | |
NO20022923D0 (no) | Inhibitorer av farnesyl-protein-transferase | |
FIU990312U0 (fi) | Kylmäsavustus kylmälaitteissa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |